Skip to content
lifestyle.small-bizsense.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ratio Therapeutics Inc.
Ratio Therapeutics Announces the Appointment of Kenan Turnacioglu to its Board of Directors
September 17, 2026
Ratio Therapeutics Enters into Research Collaboration and License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
September 9, 2026
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
July 31, 2026
/C O R R E C T I O N — Ratio Therapeutics Inc./
June 30, 2026
Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
June 30, 2026
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
May 29, 2026